CN Patent

CN104487441B — 有用于治疗癌症和自身免疫性疾病的可逆的共价吡咯并嘧啶或吡唑并嘧啶

Assigned to Pu Linsi Inferior Biopharmaceutical Co · Expires 2018-06-01 · 8y expired

What this patent protects

提供了包含具有迈克尔受体部分的可逆共价化合物的口服药物配制品，其生产方法，以及这些配制品用于治疗由此类化合物可治疗的疾病的用途，这些疾病例如癌症和自身免疫性疾病。

USPTO Abstract

提供了包含具有迈克尔受体部分的可逆共价化合物的口服药物配制品，其生产方法，以及这些配制品用于治疗由此类化合物可治疗的疾病的用途，这些疾病例如癌症和自身免疫性疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN104487441B
Jurisdiction
CN
Classification
—
Expires
2018-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Pu Linsi Inferior Biopharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.